General description
Zonisamide is a second-generation anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures, infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, and generalized tonic clonic seizure. Zonisamide is marketed in the US under the trade name Zonegran®.
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Zonegran is a registered trademark of Dainippon Sumitomo Pharma Co., Ltd.
- UPC:
- 51141514
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- Z-006-1ML
- CAS:
- 1435934-68-1
akash.verma@cenmed.com
(732) 447-1115





